disease 6,462 words KG: FTD
Contents

Frontotemporal Dementia (FTD)

Disease Info
Behavioral variant FTD (bvFTD)Progressive changes in personality, social conduct, and executive function, with early behavioral disinhibition, apathy, loss of empathy, and compulsive/ritualistic behaviors
Associated GenesACHE, AD, AKT, AMYLOID, APOE, APP, BDNF, C9orf72
KG Connections792 knowledge graph edges
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (23)

TDP-43 RNA-proteostasis failure across ALS, FTD, and AD/LATE
Score: 0.83
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.82
C9ORF72 autophagy-lysosome collapse across ALS and FTD
Score: 0.82
MAPT tau seeding and release across AD, FTD, and PD-spectrum
Score: 0.81
Stress-granule RNA-binding protein phase transition across A
Score: 0.78
TBK1-OPTN-p62 selective autophagy failure across ALS, FTD, a
Score: 0.78
ASO-mediated reduction of toxic C9orf72 dipeptide repeat pro
Score: 0.76
GRN/progranulin lysosomal insufficiency across FTD, ALS-spec
Score: 0.76
C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD
Score: 0.72
C9orf72 repeat RNA and dipeptide-repeat toxicity in ALS/FTD
Score: 0.70
Astrocyte-Neuron Metabolic Coupling Failure Precedes Neurode
Score: 0.69
TDP-43 phase-separation and nuclear-function failure in ALS/
Score: 0.69
FUS Phase Separation Dominance in FTD-TDP: Aberrant Condensa
Score: 0.68
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A
Score: 0.66
ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Pro
Score: 0.63
Nrf2 Pathway Activation Compensates for Progranulin Haploins
Score: 0.63
Nuclear TDP-43 Depletion Drives Synaptic Splicing Dysregulat
Score: 0.62
TDP-43 LLPS and proteostasis dysregulation in ALS/FTD
Score: 0.60
C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD
Score: 0.60
Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Sepa
Score: 0.56
pg 1/2Next →

Related Analyses (2)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (9)

Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40
Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40

Knowledge Graph (12 edges)

TAU associated_with FTD
TAU causes FTD
FTD inhibits MITOCHONDRIAL_PROTEINS
FTD inhibits BIOENERGETICS
FTD regulates TAU
TDP43 associated_with FTD
C9ORF72 causes FTD
VESICLE_TRAFFICKING associated_with FTD
GGGGCC_repeat causes FTD
FTD regulates MITOCHONDRIAL_PROTEINS

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.